These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24629144)

  • 1. Simvastatin down-regulates the production of interleukin-8 by neutrophil leukocytes from dyslipidemic patients.
    Marino F; Maresca AM; Castiglioni L; Cosentino M; Maio RC; Schembri L; Klersy C; Mongiardi C; Robustelli Test L; Grandi AM; Guasti L
    BMC Cardiovasc Disord; 2014 Mar; 14():37. PubMed ID: 24629144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin to modify neutrophil function in older patients with septic pneumonia (SNOOPI): study protocol for a randomised placebo-controlled trial.
    Greenwood H; Patel J; Mahida R; Wang Q; Parekh D; Dancer RC; Khiroya H; Sapey E; Thickett DR
    Trials; 2014 Aug; 15():332. PubMed ID: 25146127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up.
    Guasti L; Marino F; Cosentino M; Maio RC; Rasini E; Ferrari M; Castiglioni L; Klersy C; Gaudio G; Grandi AM; Lecchini S; Venco A
    Eur Heart J; 2008 May; 29(9):1118-26. PubMed ID: 18390537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study.
    Guasti L; Marino F; Cosentino M; Cimpanelli M; Maio RC; Klersy C; Crespi C; Restelli D; Simoni C; Franzetti I; Gaudio G; Marnini P; Grandi AM; Lecchini S; Venco A
    J Hypertens; 2006 Dec; 24(12):2423-30. PubMed ID: 17082725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial.
    Xue Y; Tao L; Wu S; Wang G; Qian L; Li J; Liao L; Tang J; Ji K
    BMC Cardiovasc Disord; 2017 May; 17(1):127. PubMed ID: 28521773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients.
    Manfredini V; Biancini GB; Vanzin CS; Dal Vesco AM; Cipriani F; Biasi L; Treméa R; Deon M; Peralba Mdo C; Wajner M; Vargas CR
    Cell Biochem Funct; 2010 Jul; 28(5):360-6. PubMed ID: 20589733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass.
    TAMAYO E; ALVAREZ FJ; ALONSO O; BUSTAMANTE R; CASTRODEZA J; SORIA S; LAJO C
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):687-94. PubMed ID: 19741581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
    Foucher C; Aubonnet P; Reichert P; Berli M; Schaeffer A; Calvo Vargas CG; Lochocka A; Belenky D; Koch HF;
    Cardiovasc Ther; 2015 Dec; 33(6):329-37. PubMed ID: 26227087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals.
    Boland AJ; Gangadharan N; Kavanagh P; Hemeryck L; Kieran J; Barry M; Walsh PT; Lucitt M
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):509-517. PubMed ID: 29764192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood mononuclear cell production of interleukin-8 and IL-8-dependent neutrophil function in hypercholesterolemic patients.
    Porreca E; Sergi R; Baccante G; Reale M; Orsini L; Febbo CD; Caselli G; Cuccurullo F; Bertini R
    Atherosclerosis; 1999 Oct; 146(2):345-50. PubMed ID: 10532690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates.
    Okopień B; Krysiak R; Kowalski J; Madej A; Belowski D; Zieliński M; Herman ZS
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):377-86. PubMed ID: 16116345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin.
    Marino F; Guasti L; Cosentino M; Ferrari M; Rasini E; Maio RC; Cimpanelli MG; Cereda E; Crespi C; Simoni C; Restelli D; Venco A; Lecchini S
    J Cardiovasc Pharmacol; 2007 May; 49(5):299-305. PubMed ID: 17513949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.
    Hu Y; Tong G; Xu W; Pan J; Ryan K; Yang R; Shuldiner AR; Gong DW; Zhu D
    Diab Vasc Dis Res; 2009 Oct; 6(4):262-8. PubMed ID: 20368220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of cytokines and chemokines associated with cardiovascular disease in Brazilian patients treated with statins for dyslipidemia.
    Pereira MM; Santos TP; Aras R; Couto RD; Atta ML; Atta AM
    Int Immunopharmacol; 2014 Jan; 18(1):66-70. PubMed ID: 24252254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial.
    Eriksson M; Budinski D; Hounslow N
    Adv Ther; 2011 Sep; 28(9):811-23. PubMed ID: 21874538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.
    Guimarães ES; Cerda A; Dorea EL; Bernik MMS; Gusukuma MC; Pinto GA; Fajardo CM; Hirata MH; Hirata RDC
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28940978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
    Waehre T; Damås JK; Gullestad L; Holm AM; Pedersen TR; Arnesen KE; Torsvik H; Frøland SS; Semb AG; Aukrust P
    J Am Coll Cardiol; 2003 May; 41(9):1460-7. PubMed ID: 12742282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.